State of the art and challenges

21-22 March, Norwegian Radium Hospital, Forskningsbygget, seminar rooms 1-2

Download programme in Word format

Monday 21 March 2011

8.30-9.00              Registration

9.00-9.15              Opening

9.15-10.15           Laszlo Tabar: Heterogeneity of in situ carcinoma. Classification of in situ subtypes based on imaging appearance. New aspects on terminology and implications for treatment and research. 

10.15-10.30         Ragnhild Falk: Incidence of ductal carcinoma in situ in Norway

10.30-10.45         Coffee

10.45-11.15         Giske Ursin: Mammographic density and breast cancer risk

11.15-11.30         Solveig Hofvind: Risk factors for benign lesions, in situ carcinoma and invasive breast cancer  in women participating in the NBCSP (risk factors)

11.30-12.15 Lars Akslen Pathology of carcinoma in situ of the breast

12.15-12.30         Vilde Haakensen :  The biology underlying mammographic density

12.30-13-30         Lunch (food to be purchased, cafeteria accepts only credit cards)

13.30-15.00         Laszlo Tabar:  Multimodality approach to the diagnosis of breast diseases.

           Multimodality approach to screening for breast cancer.

15.00-15.15         Coffee

15.15-15.45         Fredrik Wärnberg: DCIS, prognosis and risk for invasive cancer.

15.45-16.00         Therese Sørlie: Molecular diversity in carcinomas in situ of the breast

16.00-16.30         Vessela Kristensen:  Genetics and epigenetics of  carcinomas in situ of the breast  

16.30-17.00         Hege Russnes: Heterogeneity in DCIS; is it of importance, and how can it be studied?  

17.00-17.15         Concluding remarks and future goals (Solveig + Anne-Lise)

Tuesday 22 March 2011

At the Cancer Registry:

09.00-10.30         Laszlo Tabar: A New Era in the Diagnosis and Treatment of Breast Cancer.

                                         30-year experience with mammography screening

Register to Mona Hagen (MONA.HAGEN@rr-research.no) with your name and place of you work.